Literature DB >> 1426382

Differential effects of transdermal estradiol and sequential progestogens on impedance to flow within the uterine arteries of postmenopausal women.

T C Hillard1, T H Bourne, M I Whitehead, T B Crayford, W P Collins, S Campbell.   

Abstract

OBJECTIVE: To investigate the relationship between estradiol (E2), progestogen, and impedance to blood flow in the uterine artery.
SUBJECTS: Twelve postmenopausal women treated for two cycles with transdermal E2, 0.05 mg/d, with either norethindrone acetate, 0.7 mg, or medroxyprogesterone acetate, 10 mg added sequentially. MEASUREMENTS: Transvaginal ultrasonography and color flow imaging were used to measure the pulsatility index in the uterine arteries before and during the E2-only and combined E2/progestogen phases.
RESULTS: The mean pulsatility index fell to 53% of its pretreatment value within 12 days E2 administration (P < or = 0.0001) and was 66% of its pretreatment value in the combined phase (P < 0.005). Similar changes were seen in cycle 2. Time since menopause was correlated with the pretreatment pulsatility index (r = 0.674, P < 0.05) and change in pulsatility index on treatment (r = 0.856, P < 0.001).
CONCLUSION: Gonadal hormones have a profound effect on arterial tone in postmenopausal women; this action may help explain some of the beneficial effects of estrogen on arterial disease risk.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1426382     DOI: 10.1016/s0015-0282(16)55442-9

Source DB:  PubMed          Journal:  Fertil Steril        ISSN: 0015-0282            Impact factor:   7.329


  7 in total

Review 1.  Hormone replacement therapy in the aged. A state of the art review.

Authors:  S Jacobs; T C Hillard
Journal:  Drugs Aging       Date:  1996-03       Impact factor: 3.923

Review 2.  Climacteric symptoms and hormonal replacement therapy: a risk or an opportunity?

Authors:  R Lindgren
Journal:  Arch Gynecol Obstet       Date:  1993       Impact factor: 2.344

3.  Prediction of pregnancy rate of in vitro fertilization and embryo transfer in women aged 40 and over with basal uterine artery pulsatility index.

Authors:  C H Chiang; T T Hsieh; M Y Chang; C S Shiau; H C Hou; J J Hsu; Y K Soong
Journal:  J Assist Reprod Genet       Date:  2000-09       Impact factor: 3.412

Review 4.  Comparative pharmacology of newer progestogens.

Authors:  H Kuhl
Journal:  Drugs       Date:  1996-02       Impact factor: 9.546

Review 5.  Transdermal estradiol/norethisterone. A review of its pharmacological properties and clinical use in postmenopausal women.

Authors:  L R Wiseman; D McTavish
Journal:  Drugs Aging       Date:  1994-03       Impact factor: 3.923

6.  Long-term effects of transdermal and oral hormone replacement therapy on postmenopausal bone loss.

Authors:  T C Hillard; S J Whitcroft; M S Marsh; M C Ellerington; B Lees; M I Whitehead; J C Stevenson
Journal:  Osteoporos Int       Date:  1994-11       Impact factor: 4.507

7.  Prospective study on gynaecological effects of two antioestrogens tamoxifen and toremifene in postmenopausal women.

Authors:  M B Marttunen; B Cacciatore; P Hietanen; S Pyrhönen; A Tiitinen; T Wahlström; O Ylikorkala
Journal:  Br J Cancer       Date:  2001-04-06       Impact factor: 7.640

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.